MedTrace Logo

New Pre-Surgical Scoring System for Uterine Septum

NCT05823103 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2023-04-21

No results posted yet for this study

Summary

Comparing surgical outcomes of Hysteroscopic metroplasty for uterine septum when using the standard ESGE or ASRM classifications vs the novel scoring system dubbed Shawki Septum Scoring System.

Outcomes based primarily on completion of the septal correction (no residual parts) and avoiding complications, the most significant of which are uterine perforation.

Conditions

  • Septate Uterus

Interventions

DIAGNOSTIC_TEST

Shawki Septum Scoring System

Utilising the novel scoring system to facilitate feasibility and safety of hysteroscopic metroplasty for uterine septum

DIAGNOSTIC_TEST

ESHRE ASRM Classification

Utilising the current classification before performing hysteroscopic metroplasty

Sponsors & Collaborators

  • Ebtesama Hospital

    lead OTHER

Principal Investigators

  • Yehia Shawki, MRCOG · Endo-Planet

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-18
Primary Completion
2023-11-30
Completion
2023-12-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05823103 on ClinicalTrials.gov